1. ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma. Issue 4 (30th December 2020) Authors: Iseda, Norifumi; Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Morinaga, Akinari; Tomiyama, Takahiro; Toshima, Takeo; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki Journal: Hepatology communications Issue: Volume 5:Issue 4(2021) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p. Issue 2 (February 2021) Authors: Yugawa, Kyohei; Yoshizumi, Tomoharu; Mano, Yohei; Itoh, Shinji; Harada, Noboru; Ikegami, Toru; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki Journal: European journal of surgical oncology Issue: Volume 47:Issue 2(2021) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma. Issue 3 (8th December 2022) Authors: Toshida, Katsuya; Itoh, Shinji; Harada, Noboru; Morinaga, Akinari; Yugawa, Kyohei; Tomiyama, Takahiro; Kosai‐Fujimoto, Yukiko; Tomino, Takahiro; Kurihara, Takeshi; Nagao, Yoshihiro; Morita, Kazutoyo; Oda, Yoshinao; Yoshizumi, Tomoharu Journal: Cancer science Issue: Volume 114:Issue 3(2023) Page Start: 937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma. Issue 2 (24th November 2020) Authors: Yugawa, Kyohei; Itoh, Shinji; Yoshizumi, Tomoharu; Iseda, Norifumi; Tomiyama, Takahiro; Morinaga, Akinari; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki Journal: Hepatology communications Issue: Volume 5:Issue 2(2021) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune microenvironment in primary and metastatic liver cancers. Issue 1 (23rd January 2021) Authors: Itoh, Shinji; Yugawa, Kyohei; Yoshizumi, Tomoharu; Oda, Yoshinao; Mori, Masaki Journal: Hepatology research Issue: Volume 51:Issue 1(2021) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation. Issue 6 (20th October 2020) Authors: Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Imai, Daisuke; Yoshiya, Shohei; Takeishi, Kazuki; Toshima, Takeo; Harada, Noboru; Ikegami, Toru; Soejima, Yuji; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki Journal: Hepatology Issue: Volume 72:Issue 6(2020) Page Start: 1987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation. Issue 7 (26th March 2021) Authors: Itoh, Shinji; Yoshizumi, Tomoharu; Kitamura, Yoshiyuki; Yugawa, Kyohei; Iseda, Norifumi; Shimagaki, Tomonari; Nagao, Yoshihiro; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Baba, Shingo; Ishigami, Kousei; Oda, Yoshinao; Mori, Masaki Journal: Hepatology communications Issue: Volume 5:Issue 7(2021) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status. Issue 4 (23rd October 2021) Authors: Iseda, Norifumi; Itoh, Shinji; Yoshizumi, Tomoharu; Tomiyama, Takahiro; Morinaga, Akinari; Yugawa, Kyohei; Shimokawa, Masahiro; Shimagaki, Tomonari; Wang, Huanlin; Kurihara, Takeshi; Kitamura, Yoshiyuki; Nagao, Yoshihiro; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Baba, Shingo; Ishigami, K... Journal: Hepatology communications Issue: Volume 6:Issue 4(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lymphocyte‐to‐Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular Carcinoma. Issue 11 (8th November 2018) Authors: Mano, Yohei; Yoshizumi, Tomoharu; Yugawa, Kyohei; Ohira, Masafumi; Motomura, Takashi; Toshima, Takeo; Itoh, Shinji; Harada, Noboru; Ikegami, Toru; Soejima, Yuji; Maehara, Yoshihiko Journal: Liver transplantation Issue: Volume 24:Issue 11(2018) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Issue 4 (3rd March 2020) Authors: Shimokawa, Masahiro; Yoshizumi, Tomoharu; Itoh, Shinji; Iseda, Norifumi; Sakata, Kazuhito; Yugawa, Kyohei; Toshima, Takeo; Harada, Noboru; Ikegami, Toru; Mori, Masaki Journal: Cancer science Issue: Volume 111:Issue 4(2020) Page Start: 1228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗